NICOLE BODINE: Open Payments
NPI 1780981159 · GULF SHORES, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$890 in 44 payments from 16 companies in 2025. Trend: 2023 $1,042 · 2024 $1,136 · 2025 $890
Food & beverage: $890
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $175 |
| Novo Nordisk Inc | 7 | $116 |
| Paratek Pharmaceuticals, Inc. | 4 | $85 |
| Amgen Inc. | 4 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $62 |
| Viatris Specialty LLC | 3 | $60 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| Lilly USA, LLC | 2 | $48 |
| Esperion Therapeutics, Inc. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
Products named: Kerendia, NUZYRA, Wegovy, YUPELRI, LEQVIO, MOUNJARO, NEXLETOL, Ozempic.
Industry payments across AL — which companies pay providers there.
